Annexon Biosciences's market cap is currently $340.65M. The company's EPS TTM is $-0.34; its P/E ratio is ―; Annexon Biosciences is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is $-0.34. See an overview of income statement, balance sheet, and cash flow financials.
